RGP Bulletin (23 April 2014)

Notices

by date

Minimize all
Expand all

Wed

Apr

RGP and AAO One Day Closure

More details

Due to a departmental outing, the RGP and AAO Offices will be closed on Tuesday, 29 April 2014.

If any signatures or other assistance from the RGP or AAO are required on this day, please make sure to take this into consideration and contact us before or after the aforementioned times.

Current Funding Opportunities

Funding Agency	Program	Type	Area	Amount	Support Period	RGP Deadline
Israel Ministry of Science (IMOS)	France - Israel Cooperation - Maimonide-Israel Research Program	G	LS, Ch, Ph, M	Up to Euro 40,000 per year Approximately Euro 40,000 per year per project per each side will be awarded.	2 years Second year approval contingent upon submission of an application for the continuation of research funding submitted to MOST by 1 November 2015.	29/05/2014
Israel Ministry of Science (IMOS)	India - Israel Cooperation - Energy Engineering	G	LS, Ch, Ph, M	Up to US$ 30,000 per year This is the approximate amount for the Israeli side of a project. Approximately Rs. 15 lakhs per year will be awarded to the Indian side of a project.	2 years Second year funding is contingent on the submission of an application for the continuation of research funding for the second year to MOST-IL on the appropriate forms at least two months prior to the end of the first year of the project together with the annual scientific report.	22/05/2014
Israel Ministry of Energy and Water Resources (formerly Israel Ministry of National Infrastructures)	Call for Proposals 4/14	G	LS, Ch, Ph	No specification of amount is given by the agency.	Up to 3 years	22/05/2014
Israel Ministry of Agriculture (IMOA)	Special Calls - Poultry	G	LS, Ch	No specification of amount is given by the agency.	No support period is specified by the agency.	29/04/2014
Israel Defense Force (IDF) and Israel Ministry of Defense (IMOD)	Medical Research 2015 Call for Proposals	G	LS	Up to NIS 100,000 per project	12 – 18 months	05/06/2014
Keren Kayemeth LeIsrael (KKL) and the Israel Nature and Parks Authority	Joint Call for Proposals	G	LS	NIS 50,000 – 100,000 per project Funding depends on the chosen research field.	1 year	20/05/2014
TAU Consortium	Translational Awards to Develop New Treatments for Frontotemporal Dementia	G	LS	Up to US$ 400,000 per project The proposal should not overlap with existing funding. However, if additional funding from this award would demonstrably facilitate the clinical development of a new treatment, such a proposal would be considered favorably. Likewise, although each award will be capped at $400,000, additional support would be considered if it would demonstrably and directly facilitate clinical development.	Up to 2 years	08/05/2014
United States DOD - CDMRP	Lung Cancer Research Program - Career Development Award	G	LS	Up to US$ 240,000 per project Plus indirect costs.	Up to 2 years	26/05/2014
United States DOD - CDMRP	Lung Cancer Research Program - Idea Development Award	G	LS	Up to US$ 350,000 per project Plus indirect costs.	Up to 2 years	26/05/2014
United States DOD - CDMRP	Ovarian Cancer Research Program - Investigator-Initiated Research Award	G	LS	Up to US$ 450,000 per project Plus indirect costs.	Up to 3 years	26/05/2014
United States DOD - CDMRP	Ovarian Cancer Research Program - Pilot Award	G	LS	Up to US$ 225,000 per project Plus indirect costs. If requesting an optional nested Teal Postdoctoral Scholar, the maximum allowable direct costs for the entire period of performance are $300,000 plus indirect costs.	Up to 2 years	15/05/2014

Type

G: Grant
F: Fellowship

Area

LS: Life Sciences
Ch: Chemistry
Ph: Physics
M: Math
ST: Science Teaching

NIH-Specific RFAs and Program Announcements

(view all calls and NIH Notices for the weeks ending 11 April 2014 and 18 April 2014)

RFA	RFA Title	RFA Submission Date(s)
RFA-FD-14-025	Development of Realistic In Vitro Studies to Assess Robustness of Dose Counters/Indicators in Metered Dose Inhalers (U01)	June 01, 2014
RFA-MH-15-500	Dimensional Approaches to Research Classification in Psychiatric Disorders (R01)	October 03, 2014
PAR-14-173	Brain Somatic Mosaicism and its Role in Psychiatric Disorders (U01)	June 24, 2014; February 24, 2015; October 23, 2015; June 24, 2016; February 24, 2017, by 5:00 PM local time of applicant organization.
PAR-14-174	Brain Somatic Mosaicism and its Role in Psychiatric Disorders (Collaborative U01)	June 24, 2014; February 24, 2015; October 23, 2015; June 24, 2016; February 24, 2017, by 5:00 PM local time of applicant organization.
RFA-FD-14-019	Evaluation of Iron Species in Healthy Subjects Treated with Generic and Reference Sodium Ferric Gluconate (U01)	June 18, 2014
RFA-FD-14-020	Prospective Studies on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft survivals (U01)	June 20, 2014
RFA-FD-14-021	Retrospective Analysis on the Impact of Generic Immunosuppressants on Acute Rejection and Long Term Graft Survivals (U01)	June 20, 2014
RFA-FD-14-023	The Effect of Different Preparation Methods on the In Vitro and In Vivo Performance of Solid Dispersion Formulations (U01)	June 18, 2014
RFA-FD-14-024	Pharmacokinetic and Pharmacodynamic (PK-PD) Studies of Cardiovascular Drugs (U01)	June 01, 2014
RFA-RM-14-005	Undiagnosed Diseases Gene Function Research (R21)	June 23, 2014
PA-14-180	mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R01)	Standard NIH receipt dates
PA-14-181	mHealth Tools for Underserved Populations with Chronic Conditions to Promote Effective Patient-Provider Communication, Adherence to Treatment and Self-Management (R21)	Standard NIH receipt dates

How to Get a Bite of NIH's Billion-Dollar Funding Pie

As per WIS management instruction, grant proposals must be submitted for evaluation by the RGP, with a budget approved by Finance, at least one week to 10 days prior to the funding agency’s deadline. Failure to do so may result in delayed or aborted activation of the award, as well as in an increased rate of Shiryun from the KAMAR.